These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6211330)

  • 1. [Effects of a natural mucopolysaccharide-fibrinolytic complex on venous thrombosis and on the clearing factor].
    Pirani R; Pozzar C; De Lorenzi E
    Clin Ter; 1982 Mar; 100(6):575-96. PubMed ID: 6211330
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate, and heparin.
    Hoppensteadt D; Racanelli A; Walenga JM; Fareed J
    Semin Thromb Hemost; 1989 Oct; 15(4):378-85. PubMed ID: 2530633
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness and tolerability of heparan sulfate in the treatment of superficial thrombophlebitis. Controlled clinical study vs sulodexide].
    Messa G; La Placa G; Puccetti L; Di Perri T
    Minerva Cardioangiol; 1997 Apr; 45(4):147-53. PubMed ID: 9213829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental venous thrombosis in rats: a new way to express the results.
    Maggi A; Abbadini M
    Thromb Haemost; 1986 Dec; 56(3):419-20. PubMed ID: 3563972
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the efficacy of thrombolytic agents].
    Urbaniuk KG
    Klin Med (Mosk); 1968 Aug; 46(8):94-7. PubMed ID: 5707111
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic effects of glucagon in acute myocardial infarct, total A-V block and mitral stenosis].
    Gavrilescu S; Streian C; Pop T; Vicaş E
    Med Interna (Bucur); 1971 May; 23(5):573-82. PubMed ID: 5567983
    [No Abstract]   [Full Text] [Related]  

  • 7. [What is guaranteed in fibrinolytic therapy of deep venous thrombosis?].
    Seifried E
    Internist (Berl); 1990 Nov; 31(11):689-97. PubMed ID: 2289854
    [No Abstract]   [Full Text] [Related]  

  • 8. [Guidelines and results of consequent fibrinolytic therapy in phlegmasia cerulea dolens].
    Paquet KJ; Popov S; Egli H
    Dtsch Med Wochenschr; 1970 Apr; 95(16):903-4. PubMed ID: 5439547
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombolytic treatment of venous thrombosis].
    Straub H
    Verh Dtsch Ges Inn Med; 1990; 96():343-54. PubMed ID: 2092452
    [No Abstract]   [Full Text] [Related]  

  • 10. [Further data on therapeutic fibrinolysis].
    Schmutzler R
    Helv Med Acta; 1963 Nov; 30(4):608-14. PubMed ID: 5878830
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term therapy with anticoagulants].
    Remde W
    Z Gesamte Inn Med; 1973 Jan; 28(2):23-7. PubMed ID: 4632544
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic defibrination in the treatment of thrombotic disease.
    Bell WR; Pitney WR; Goodwin JF
    Lancet; 1968 Mar; 1(7541):490-3. PubMed ID: 4170831
    [No Abstract]   [Full Text] [Related]  

  • 13. [First report on experience with the combined treatment of thrombosis of the central retinal vein or its branches with an aggregation inhibitor (Colfarit) (author's transl)].
    Weimershaus HJ
    Klin Monbl Augenheilkd; 1973 Dec; 163(6):765-8. PubMed ID: 4274923
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical usefulness of D-dimer: evaluation during fibrinolytic treatment of venous thrombosis or myocardial infarction.
    Simank HG; Simon M; Bode C; Zimmermann R; Kübler W; Weber E
    Thromb Res; 1989 Nov; 56(4):541-6. PubMed ID: 2609291
    [No Abstract]   [Full Text] [Related]  

  • 15. [1st results in thrombolitic treatment with urokinase in myocardial infarct and premonitory syndromes].
    Brochier M; Raynaud R; Griguer P; Fauchier JP; Ginies G; Bienvenu P; Archambaud D
    Ann Cardiol Angeiol (Paris); 1973; 22(3):211-22. PubMed ID: 4731539
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antithrombogenic action of a new extract: 3GS].
    Rusconi C; Orlando G
    Minerva Cardioangiol; 1975 Sep; 23(9):565-70. PubMed ID: 125860
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial.
    Pérez-Gómez F; Salvador A; Zumalde J; Iriarte JA; Berjón J; Alegría E; Almería C; Bover R; Herrera D; Fernández C
    Eur Heart J; 2006 Apr; 27(8):960-7. PubMed ID: 16330464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombolytin and anticoagulants in the treatment of patients with acute thrombosis of the veins of the lower limbs].
    Koniukhov SG; Tarasova LN; Martyshkin GP; Rommer SI; Rybkin AV
    Vestn Khir Im I I Grek; 1972 Jul; 109(7):66-8. PubMed ID: 4650559
    [No Abstract]   [Full Text] [Related]  

  • 19. [Are there indications for the administration of thrombolytic agents?].
    Bieger R; Loeliger EA
    Ned Tijdschr Geneeskd; 1972 Nov; 116(45):2042-6. PubMed ID: 4639588
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombolytics. Fundamentals and rules of use].
    Charbonnier B; Pacouret G
    Rev Prat; 1998 May; 48(10):1137-40. PubMed ID: 9781161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.